Get Real Time Here
| Open0.510 | Close0.503 |
| Vol / Avg.54.603K / 422.426K | Mkt Cap19.109M |
| Day Range0.490 - 0.515 | 52 Wk Range0.189 - 0.740 |
Catalyst Biosciences Stock (NASDAQ:CBIO), Quotes and News Summary
Catalyst Biosciences Stock (NASDAQ: CBIO) stock price, news, charts, stock research, profile.
| Open0.510 | Close0.503 |
| Vol / Avg.54.603K / 422.426K | Mkt Cap19.109M |
| Day Range0.490 - 0.515 | 52 Wk Range0.189 - 0.740 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.070 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-11-15 | Raymond James | Timur Ivannikov | Downgrades | OutperformMarket Perform | - | - | - |
| 2021-08-06 | Raymond James | Steven Seedhouse | Maintains | Outperform | Lowers | 19.00 | 18.00 |
| 2021-04-29 | Raymond James | Timur Ivannikov | Maintains | Outperform | Raises | 18.00 | 19.00 |
| 2021-02-10 | Piper Sandler | Tyler Van Buren | Initiates Coverage On | Overweight | Announces | - | 15.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CBIO | Catalyst Biosciences | 0.64% | 19.1M |
| VINC | Vincerx Pharma | 3.37% | 19.7M |
| GLTO | Galecto | 0% | 15.5M |
| VIRI | Virios Therapeutics | 0.2% | 18.1M |
| ACXP | Acurx Pharmaceuticals | 0% | 19.5M |
How do I buy Catalyst Biosciences (CBIO) stock?
You can purchase shares of Catalyst Biosciences (NASDAQ: CBIO) through any online brokerage.
Who are Catalyst Biosciences's (CBIO) competitors?
Other companies in Catalyst Biosciences’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Virios Therapeutics (NASDAQ:VIRI), Acurx Pharmaceuticals (NASDAQ:ACXP) and Evaxion Biotech (NASDAQ:EVAX).
What is the target price for Catalyst Biosciences (CBIO) stock?
The latest price target for Catalyst Biosciences (NASDAQ: CBIO) was reported by Raymond James on Monday, November 15, 2021. The analyst firm set a price target for 0.00 expecting CBIO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Catalyst Biosciences (CBIO)?
The stock price for Catalyst Biosciences (NASDAQ: CBIO) is $0.5032 last updated Today at September 26, 2023 at 8:00 PM UTC.
Does Catalyst Biosciences (CBIO) pay a dividend?
There is no dividend information for Catalyst Biosciences.
When is Catalyst Biosciences (NASDAQ:CBIO) reporting earnings?
Catalyst Biosciences’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Catalyst Biosciences (CBIO) going to split?
There is no upcoming split for Catalyst Biosciences.
What sector and industry does Catalyst Biosciences (CBIO) operate in?
Catalyst Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Catalyst Biosciences Stock (NASDAQ:CBIO), Quotes and News Summary
Catalyst Biosciences Stock (NASDAQ: CBIO) stock price, news, charts, stock research, profile.
| Open0.510 | Close0.503 |
| Vol / Avg.54.603K / 422.426K | Mkt Cap19.109M |
| Day Range0.490 - 0.515 | 52 Wk Range0.189 - 0.740 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.070 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-11-15 | Raymond James | Timur Ivannikov | Downgrades | OutperformMarket Perform | - | - | - |
| 2021-08-06 | Raymond James | Steven Seedhouse | Maintains | Outperform | Lowers | 19.00 | 18.00 |
| 2021-04-29 | Raymond James | Timur Ivannikov | Maintains | Outperform | Raises | 18.00 | 19.00 |
| 2021-02-10 | Piper Sandler | Tyler Van Buren | Initiates Coverage On | Overweight | Announces | - | 15.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CBIO | Catalyst Biosciences | 0.64% | 19.1M |
| VINC | Vincerx Pharma | 3.37% | 19.7M |
| GLTO | Galecto | 0% | 15.5M |
| VIRI | Virios Therapeutics | 0.2% | 18.1M |
| ACXP | Acurx Pharmaceuticals | 0% | 19.5M |
How do I buy Catalyst Biosciences (CBIO) stock?
You can purchase shares of Catalyst Biosciences (NASDAQ: CBIO) through any online brokerage.
Who are Catalyst Biosciences's (CBIO) competitors?
Other companies in Catalyst Biosciences’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Virios Therapeutics (NASDAQ:VIRI), Acurx Pharmaceuticals (NASDAQ:ACXP) and Evaxion Biotech (NASDAQ:EVAX).
What is the target price for Catalyst Biosciences (CBIO) stock?
The latest price target for Catalyst Biosciences (NASDAQ: CBIO) was reported by Raymond James on Monday, November 15, 2021. The analyst firm set a price target for 0.00 expecting CBIO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Catalyst Biosciences (CBIO)?
The stock price for Catalyst Biosciences (NASDAQ: CBIO) is $0.5032 last updated Today at September 26, 2023 at 8:00 PM UTC.
Does Catalyst Biosciences (CBIO) pay a dividend?
There is no dividend information for Catalyst Biosciences.
When is Catalyst Biosciences (NASDAQ:CBIO) reporting earnings?
Catalyst Biosciences’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Catalyst Biosciences (CBIO) going to split?
There is no upcoming split for Catalyst Biosciences.
What sector and industry does Catalyst Biosciences (CBIO) operate in?
Catalyst Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Catalyst Biosciences Stock (NASDAQ:CBIO), Quotes and News Summary
Catalyst Biosciences Stock (NASDAQ: CBIO) stock price, news, charts, stock research, profile.
| Open0.510 | Close0.503 |
| Vol / Avg.54.603K / 422.426K | Mkt Cap19.109M |
| Day Range0.490 - 0.515 | 52 Wk Range0.189 - 0.740 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.070 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-11-15 | Raymond James | Timur Ivannikov | Downgrades | OutperformMarket Perform | - | - | - |
| 2021-08-06 | Raymond James | Steven Seedhouse | Maintains | Outperform | Lowers | 19.00 | 18.00 |
| 2021-04-29 | Raymond James | Timur Ivannikov | Maintains | Outperform | Raises | 18.00 | 19.00 |
| 2021-02-10 | Piper Sandler | Tyler Van Buren | Initiates Coverage On | Overweight | Announces | - | 15.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CBIO | Catalyst Biosciences | 0.64% | 19.1M |
| VINC | Vincerx Pharma | 3.37% | 19.7M |
| GLTO | Galecto | 0% | 15.5M |
| VIRI | Virios Therapeutics | 0.2% | 18.1M |
| ACXP | Acurx Pharmaceuticals | 0% | 19.5M |
How do I buy Catalyst Biosciences (CBIO) stock?
You can purchase shares of Catalyst Biosciences (NASDAQ: CBIO) through any online brokerage.
Who are Catalyst Biosciences's (CBIO) competitors?
Other companies in Catalyst Biosciences’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Virios Therapeutics (NASDAQ:VIRI), Acurx Pharmaceuticals (NASDAQ:ACXP) and Evaxion Biotech (NASDAQ:EVAX).
What is the target price for Catalyst Biosciences (CBIO) stock?
The latest price target for Catalyst Biosciences (NASDAQ: CBIO) was reported by Raymond James on Monday, November 15, 2021. The analyst firm set a price target for 0.00 expecting CBIO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Catalyst Biosciences (CBIO)?
The stock price for Catalyst Biosciences (NASDAQ: CBIO) is $0.5032 last updated Today at September 26, 2023 at 8:00 PM UTC.
Does Catalyst Biosciences (CBIO) pay a dividend?
There is no dividend information for Catalyst Biosciences.
When is Catalyst Biosciences (NASDAQ:CBIO) reporting earnings?
Catalyst Biosciences’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Catalyst Biosciences (CBIO) going to split?
There is no upcoming split for Catalyst Biosciences.
What sector and industry does Catalyst Biosciences (CBIO) operate in?
Catalyst Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Catalyst Biosciences Stock (NASDAQ:CBIO), Quotes and News Summary
Catalyst Biosciences Stock (NASDAQ: CBIO) stock price, news, charts, stock research, profile.
| Open0.510 | Close0.503 |
| Vol / Avg.54.603K / 422.426K | Mkt Cap19.109M |
| Day Range0.490 - 0.515 | 52 Wk Range0.189 - 0.740 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.070 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-11-15 | Raymond James | Timur Ivannikov | Downgrades | OutperformMarket Perform | - | - | - |
| 2021-08-06 | Raymond James | Steven Seedhouse | Maintains | Outperform | Lowers | 19.00 | 18.00 |
| 2021-04-29 | Raymond James | Timur Ivannikov | Maintains | Outperform | Raises | 18.00 | 19.00 |
| 2021-02-10 | Piper Sandler | Tyler Van Buren | Initiates Coverage On | Overweight | Announces | - | 15.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CBIO | Catalyst Biosciences | 0.64% | 19.1M |
| VINC | Vincerx Pharma | 3.37% | 19.7M |
| GLTO | Galecto | 0% | 15.5M |
| VIRI | Virios Therapeutics | 0.2% | 18.1M |
| ACXP | Acurx Pharmaceuticals | 0% | 19.5M |
How do I buy Catalyst Biosciences (CBIO) stock?
You can purchase shares of Catalyst Biosciences (NASDAQ: CBIO) through any online brokerage.
Who are Catalyst Biosciences's (CBIO) competitors?
Other companies in Catalyst Biosciences’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Virios Therapeutics (NASDAQ:VIRI), Acurx Pharmaceuticals (NASDAQ:ACXP) and Evaxion Biotech (NASDAQ:EVAX).
What is the target price for Catalyst Biosciences (CBIO) stock?
The latest price target for Catalyst Biosciences (NASDAQ: CBIO) was reported by Raymond James on Monday, November 15, 2021. The analyst firm set a price target for 0.00 expecting CBIO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Catalyst Biosciences (CBIO)?
The stock price for Catalyst Biosciences (NASDAQ: CBIO) is $0.5032 last updated Today at September 26, 2023 at 8:00 PM UTC.
Does Catalyst Biosciences (CBIO) pay a dividend?
There is no dividend information for Catalyst Biosciences.
When is Catalyst Biosciences (NASDAQ:CBIO) reporting earnings?
Catalyst Biosciences’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Catalyst Biosciences (CBIO) going to split?
There is no upcoming split for Catalyst Biosciences.
What sector and industry does Catalyst Biosciences (CBIO) operate in?
Catalyst Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Catalyst Biosciences Stock (NASDAQ:CBIO), Quotes and News Summary
Catalyst Biosciences Stock (NASDAQ: CBIO) stock price, news, charts, stock research, profile.
| Open0.510 | Close0.503 |
| Vol / Avg.54.603K / 422.426K | Mkt Cap19.109M |
| Day Range0.490 - 0.515 | 52 Wk Range0.189 - 0.740 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.070 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-11-15 | Raymond James | Timur Ivannikov | Downgrades | OutperformMarket Perform | - | - | - |
| 2021-08-06 | Raymond James | Steven Seedhouse | Maintains | Outperform | Lowers | 19.00 | 18.00 |
| 2021-04-29 | Raymond James | Timur Ivannikov | Maintains | Outperform | Raises | 18.00 | 19.00 |
| 2021-02-10 | Piper Sandler | Tyler Van Buren | Initiates Coverage On | Overweight | Announces | - | 15.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CBIO | Catalyst Biosciences | 0.64% | 19.1M |
| VINC | Vincerx Pharma | 3.37% | 19.7M |
| GLTO | Galecto | 0% | 15.5M |
| VIRI | Virios Therapeutics | 0.2% | 18.1M |
| ACXP | Acurx Pharmaceuticals | 0% | 19.5M |
How do I buy Catalyst Biosciences (CBIO) stock?
You can purchase shares of Catalyst Biosciences (NASDAQ: CBIO) through any online brokerage.
Who are Catalyst Biosciences's (CBIO) competitors?
Other companies in Catalyst Biosciences’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Virios Therapeutics (NASDAQ:VIRI), Acurx Pharmaceuticals (NASDAQ:ACXP) and Evaxion Biotech (NASDAQ:EVAX).
What is the target price for Catalyst Biosciences (CBIO) stock?
The latest price target for Catalyst Biosciences (NASDAQ: CBIO) was reported by Raymond James on Monday, November 15, 2021. The analyst firm set a price target for 0.00 expecting CBIO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Catalyst Biosciences (CBIO)?
The stock price for Catalyst Biosciences (NASDAQ: CBIO) is $0.5032 last updated Today at September 26, 2023 at 8:00 PM UTC.
Does Catalyst Biosciences (CBIO) pay a dividend?
There is no dividend information for Catalyst Biosciences.
When is Catalyst Biosciences (NASDAQ:CBIO) reporting earnings?
Catalyst Biosciences’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Catalyst Biosciences (CBIO) going to split?
There is no upcoming split for Catalyst Biosciences.
What sector and industry does Catalyst Biosciences (CBIO) operate in?
Catalyst Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Catalyst Biosciences Stock (NASDAQ:CBIO), Quotes and News Summary
Catalyst Biosciences Stock (NASDAQ: CBIO) stock price, news, charts, stock research, profile.
| Open0.510 | Close0.503 |
| Vol / Avg.54.603K / 422.426K | Mkt Cap19.109M |
| Day Range0.490 - 0.515 | 52 Wk Range0.189 - 0.740 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.070 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-11-15 | Raymond James | Timur Ivannikov | Downgrades | OutperformMarket Perform | - | - | - |
| 2021-08-06 | Raymond James | Steven Seedhouse | Maintains | Outperform | Lowers | 19.00 | 18.00 |
| 2021-04-29 | Raymond James | Timur Ivannikov | Maintains | Outperform | Raises | 18.00 | 19.00 |
| 2021-02-10 | Piper Sandler | Tyler Van Buren | Initiates Coverage On | Overweight | Announces | - | 15.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CBIO | Catalyst Biosciences | 0.64% | 19.1M |
| VINC | Vincerx Pharma | 3.37% | 19.7M |
| GLTO | Galecto | 0% | 15.5M |
| VIRI | Virios Therapeutics | 0.2% | 18.1M |
| ACXP | Acurx Pharmaceuticals | 0% | 19.5M |
How do I buy Catalyst Biosciences (CBIO) stock?
You can purchase shares of Catalyst Biosciences (NASDAQ: CBIO) through any online brokerage.
Who are Catalyst Biosciences's (CBIO) competitors?
Other companies in Catalyst Biosciences’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Virios Therapeutics (NASDAQ:VIRI), Acurx Pharmaceuticals (NASDAQ:ACXP) and Evaxion Biotech (NASDAQ:EVAX).
What is the target price for Catalyst Biosciences (CBIO) stock?
The latest price target for Catalyst Biosciences (NASDAQ: CBIO) was reported by Raymond James on Monday, November 15, 2021. The analyst firm set a price target for 0.00 expecting CBIO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Catalyst Biosciences (CBIO)?
The stock price for Catalyst Biosciences (NASDAQ: CBIO) is $0.5032 last updated Today at September 26, 2023 at 8:00 PM UTC.
Does Catalyst Biosciences (CBIO) pay a dividend?
There is no dividend information for Catalyst Biosciences.
When is Catalyst Biosciences (NASDAQ:CBIO) reporting earnings?
Catalyst Biosciences’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Catalyst Biosciences (CBIO) going to split?
There is no upcoming split for Catalyst Biosciences.
What sector and industry does Catalyst Biosciences (CBIO) operate in?
Catalyst Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Catalyst Biosciences Stock (NASDAQ:CBIO), Quotes and News Summary
Catalyst Biosciences Stock (NASDAQ: CBIO) stock price, news, charts, stock research, profile.
| Open0.510 | Close0.503 |
| Vol / Avg.54.603K / 422.426K | Mkt Cap19.109M |
| Day Range0.490 - 0.515 | 52 Wk Range0.189 - 0.740 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.070 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-11-15 | Raymond James | Timur Ivannikov | Downgrades | OutperformMarket Perform | - | - | - |
| 2021-08-06 | Raymond James | Steven Seedhouse | Maintains | Outperform | Lowers | 19.00 | 18.00 |
| 2021-04-29 | Raymond James | Timur Ivannikov | Maintains | Outperform | Raises | 18.00 | 19.00 |
| 2021-02-10 | Piper Sandler | Tyler Van Buren | Initiates Coverage On | Overweight | Announces | - | 15.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CBIO | Catalyst Biosciences | 0.64% | 19.1M |
| VINC | Vincerx Pharma | 3.37% | 19.7M |
| GLTO | Galecto | 0% | 15.5M |
| VIRI | Virios Therapeutics | 0.2% | 18.1M |
| ACXP | Acurx Pharmaceuticals | 0% | 19.5M |
How do I buy Catalyst Biosciences (CBIO) stock?
You can purchase shares of Catalyst Biosciences (NASDAQ: CBIO) through any online brokerage.
Who are Catalyst Biosciences's (CBIO) competitors?
Other companies in Catalyst Biosciences’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Virios Therapeutics (NASDAQ:VIRI), Acurx Pharmaceuticals (NASDAQ:ACXP) and Evaxion Biotech (NASDAQ:EVAX).
What is the target price for Catalyst Biosciences (CBIO) stock?
The latest price target for Catalyst Biosciences (NASDAQ: CBIO) was reported by Raymond James on Monday, November 15, 2021. The analyst firm set a price target for 0.00 expecting CBIO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Catalyst Biosciences (CBIO)?
The stock price for Catalyst Biosciences (NASDAQ: CBIO) is $0.5032 last updated Today at September 26, 2023 at 8:00 PM UTC.
Does Catalyst Biosciences (CBIO) pay a dividend?
There is no dividend information for Catalyst Biosciences.
When is Catalyst Biosciences (NASDAQ:CBIO) reporting earnings?
Catalyst Biosciences’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Catalyst Biosciences (CBIO) going to split?
There is no upcoming split for Catalyst Biosciences.
What sector and industry does Catalyst Biosciences (CBIO) operate in?
Catalyst Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Catalyst Biosciences Stock (NASDAQ:CBIO), Quotes and News Summary
Catalyst Biosciences Stock (NASDAQ: CBIO) stock price, news, charts, stock research, profile.
| Open0.510 | Close0.503 |
| Vol / Avg.54.603K / 422.426K | Mkt Cap19.109M |
| Day Range0.490 - 0.515 | 52 Wk Range0.189 - 0.740 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.070 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-11-15 | Raymond James | Timur Ivannikov | Downgrades | OutperformMarket Perform | - | - | - |
| 2021-08-06 | Raymond James | Steven Seedhouse | Maintains | Outperform | Lowers | 19.00 | 18.00 |
| 2021-04-29 | Raymond James | Timur Ivannikov | Maintains | Outperform | Raises | 18.00 | 19.00 |
| 2021-02-10 | Piper Sandler | Tyler Van Buren | Initiates Coverage On | Overweight | Announces | - | 15.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CBIO | Catalyst Biosciences | 0.64% | 19.1M |
| VINC | Vincerx Pharma | 3.37% | 19.7M |
| GLTO | Galecto | 0% | 15.5M |
| VIRI | Virios Therapeutics | 0.2% | 18.1M |
| ACXP | Acurx Pharmaceuticals | 0% | 19.5M |
How do I buy Catalyst Biosciences (CBIO) stock?
You can purchase shares of Catalyst Biosciences (NASDAQ: CBIO) through any online brokerage.
Who are Catalyst Biosciences's (CBIO) competitors?
Other companies in Catalyst Biosciences’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Virios Therapeutics (NASDAQ:VIRI), Acurx Pharmaceuticals (NASDAQ:ACXP) and Evaxion Biotech (NASDAQ:EVAX).
What is the target price for Catalyst Biosciences (CBIO) stock?
The latest price target for Catalyst Biosciences (NASDAQ: CBIO) was reported by Raymond James on Monday, November 15, 2021. The analyst firm set a price target for 0.00 expecting CBIO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Catalyst Biosciences (CBIO)?
The stock price for Catalyst Biosciences (NASDAQ: CBIO) is $0.5032 last updated Today at September 26, 2023 at 8:00 PM UTC.
Does Catalyst Biosciences (CBIO) pay a dividend?
There is no dividend information for Catalyst Biosciences.
When is Catalyst Biosciences (NASDAQ:CBIO) reporting earnings?
Catalyst Biosciences’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Catalyst Biosciences (CBIO) going to split?
There is no upcoming split for Catalyst Biosciences.
What sector and industry does Catalyst Biosciences (CBIO) operate in?
Catalyst Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Catalyst Biosciences Stock (NASDAQ:CBIO), Quotes and News Summary
Catalyst Biosciences Stock (NASDAQ: CBIO) stock price, news, charts, stock research, profile.
| Open0.510 | Close0.503 |
| Vol / Avg.54.603K / 422.426K | Mkt Cap19.109M |
| Day Range0.490 - 0.515 | 52 Wk Range0.189 - 0.740 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.070 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-11-15 | Raymond James | Timur Ivannikov | Downgrades | OutperformMarket Perform | - | - | - |
| 2021-08-06 | Raymond James | Steven Seedhouse | Maintains | Outperform | Lowers | 19.00 | 18.00 |
| 2021-04-29 | Raymond James | Timur Ivannikov | Maintains | Outperform | Raises | 18.00 | 19.00 |
| 2021-02-10 | Piper Sandler | Tyler Van Buren | Initiates Coverage On | Overweight | Announces | - | 15.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CBIO | Catalyst Biosciences | 0.64% | 19.1M |
| VINC | Vincerx Pharma | 3.37% | 19.7M |
| GLTO | Galecto | 0% | 15.5M |
| VIRI | Virios Therapeutics | 0.2% | 18.1M |
| ACXP | Acurx Pharmaceuticals | 0% | 19.5M |
How do I buy Catalyst Biosciences (CBIO) stock?
You can purchase shares of Catalyst Biosciences (NASDAQ: CBIO) through any online brokerage.
Who are Catalyst Biosciences's (CBIO) competitors?
Other companies in Catalyst Biosciences’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Virios Therapeutics (NASDAQ:VIRI), Acurx Pharmaceuticals (NASDAQ:ACXP) and Evaxion Biotech (NASDAQ:EVAX).
What is the target price for Catalyst Biosciences (CBIO) stock?
The latest price target for Catalyst Biosciences (NASDAQ: CBIO) was reported by Raymond James on Monday, November 15, 2021. The analyst firm set a price target for 0.00 expecting CBIO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Catalyst Biosciences (CBIO)?
The stock price for Catalyst Biosciences (NASDAQ: CBIO) is $0.5032 last updated Today at September 26, 2023 at 8:00 PM UTC.
Does Catalyst Biosciences (CBIO) pay a dividend?
There is no dividend information for Catalyst Biosciences.
When is Catalyst Biosciences (NASDAQ:CBIO) reporting earnings?
Catalyst Biosciences’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Catalyst Biosciences (CBIO) going to split?
There is no upcoming split for Catalyst Biosciences.
What sector and industry does Catalyst Biosciences (CBIO) operate in?
Catalyst Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.